GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 67 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $327,873 | +219.3% | 127,577 | +153.5% | 0.00% | – |
Q4 2023 | $102,677 | +45.5% | 50,332 | +39.0% | 0.00% | – |
Q2 2023 | $70,590 | -69.4% | 36,200 | -56.3% | 0.00% | -100.0% |
Q1 2023 | $230,462 | -67.5% | 82,900 | -59.7% | 0.00% | -50.0% |
Q4 2022 | $709,682 | +21.1% | 205,705 | -9.8% | 0.00% | 0.0% |
Q3 2022 | $586,000 | +41.5% | 227,944 | +33.2% | 0.00% | +100.0% |
Q2 2022 | $414,000 | +216.0% | 171,104 | +438.9% | 0.00% | – |
Q1 2022 | $131,000 | -96.4% | 31,753 | -92.0% | 0.00% | -100.0% |
Q2 2021 | $3,621,000 | +58.3% | 396,659 | +63.5% | 0.01% | +33.3% |
Q1 2021 | $2,288,000 | +208.4% | 242,599 | +117.1% | 0.01% | +50.0% |
Q2 2020 | $742,000 | +466.4% | 111,760 | +395.7% | 0.00% | +300.0% |
Q1 2020 | $131,000 | -7.1% | 22,548 | +43.2% | 0.00% | – |
Q4 2019 | $141,000 | -30.5% | 15,750 | -13.5% | 0.00% | -100.0% |
Q2 2019 | $203,000 | – | 18,206 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |